Comparing efficacy and safety of first-line treatment of metastatic renal cell carcinoma: A Bayesian network meta-regression analysis

BACKGROUND: This Bayesian network meta-regression analysis provides a head-to-head comparison of first-line therapeutic immune checkpoint inhibitors (ICI) and tyrosine kinase inhibitors (TKI) combinations for metastatic renal cell carcinoma (mRCC) using median follow-up time as covariate. METHODS: W...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Suyang, Xv, Zhiyuan, Chen, Xi, Wang, Shurui, Lu, Hai, Li, Jiaqi, Guo, Xinglin, Yang, Jinghua, Liu, Chengjiang, Wang, Yaoguang, Wang, Hongwu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9992527/
https://www.ncbi.nlm.nih.gov/pubmed/36910649
http://dx.doi.org/10.3389/fonc.2023.1072634

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9992527/
https://www.ncbi.nlm.nih.gov/pubmed/36910649
http://dx.doi.org/10.3389/fonc.2023.1072634

Ejemplares similares